Genetic Testing in Prostate Cancer: Clinical Implications for Early Detection and Management of Localized and Advanced Disease Webcast (2022)

CME Available: https://auau.auanet.org/node/36044

LEARNING OBJECTIVES

At the conclusion of this course, participants will be able to:

1. Counsel men with BRCA1/2 mutations, Lynch syndrome, and other key inherited syndromes regarding their prostate cancer risk and appropriate strategies for cancer screening.

2. Identify the criteria for genetic testing of prostate cancer patients, the gene panels available, and options for testing these men.

3. Interpret results of genetic testing and relay this information to patients in order to facilitate shared decision making based on the test results.

4. Utilize the results of genetic testing to improve outcomes among patients with metastatic prostate cancer, including recommendations regarding PARP-inhibition, chemotherapy, and immunotherapy.